Cytokine profiling in patients with VCP-associated disease

Clinical and Translational Science

Volumn 7, Issue 1, 2014, Pages 29-32

  Dec, Eric ^a   Rana, Prachi ^a   Katheria, Veeral ^a   Dec, Rachel ^a   Khare, Manaswitha ^a   Nalbandian, Angèle ^a   Leu, Szu Yun ^b   Radom Aizik, Shlomit ^b   Llewellyn, Katrina ^a   Benmohamed, Lbachir ^a   Zaldivar, Frank ^b   Kimonis, Virginia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokines; IBMPFD; VCP

Indexed keywords

CYTOKINES; IBMPFD; VCP;

ADENOSINE TRIPHOSPHATASES; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CYTOKINES; EPIDERMAL GROWTH FACTOR; FRONTOTEMPORAL DEMENTIA; HUMANS; INTERLEUKIN-4; INTERLEUKIN-6; MUSCLE DEVELOPMENT; MUSCULAR ATROPHY; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; MYOSITIS, INCLUSION BODY; OSTEITIS DEFORMANS; SIGNAL TRANSDUCTION; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894062649     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/cts.12117     Document Type: Article

References (27)

1. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol. 2005; 98: 911-917.
2. Liu Y, Hei Y, Shu Q, Dong J, Gao Y, Fu H, Zheng X, Yang G. VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma. PloS One. 2012; 7(4): e35800.
3. Kawakami M, Pekala PH, Lane MD, Cerami A. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci USA. 1982; 79: 912-916.
4. Horsley V, Jansen KM, Mills ST, Pavlath GK. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell. 2003; 113: 483-494.
5. St Clair JA, Meyer-Demarest SD, Ham RG. Improved medium with EGF and BSA for differentiated human skeletal muscle cells. Muscle Nerve. 1992; 15: 774-749.
6. Vesa J, Su H, Watts GD, Krause S, Walter MC, Martin B, Smith C, Wallace DC, Kimonis VE. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul Disord. 2009; 19: 766-772.
7. Ju JS, Weihl CC. p97/VCP at the intersection of the autophagy and the ubiquitin proteasome system. Autophagy. 2010; 6: 283-285.
8. Isakov E, Stanhill A. Stalled proteasomes are directly relieved by P97 recruitment. J Biol Chem. 2011; 286: 30274-30283.
9. Ikeda Y, Demartino GN, Brown MS, Lee JN, Goldstein JL, Ye J. Regulated endoplasmic reticulum-associated degradation of a polytopic protein: p97 recruits proteasomes to Insig-1 before extraction from membranes. J Biol Chem. 2009; 284: 34889-34900.
10. Meyer H, Bug M, Bremer S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol. 2012; 14: 117-123.
11. Rouiller I, DeLaBarre B, May AP, Weis WI, Brunger AT, Milligan RA, Wilson-Kubalek EM. Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle. Nat Struct Biol. 2002; 9: 950-957.
12. Asai T, Tomita Y, Nakatsuka S, Hoshida Y, Myoui A, Yoshikawa H, Aozasa K. VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res: Gann. 2002; 93: 296-304.
13. Mehta S, Khare M, Ramani R, Watts GD, Simon M, Osann KE, Donkervoort S, Dec E, Nalbandian A, Platt J, et al. Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia. Clin Genet. 2013; 83:422-431.
14. Miller SC, Ito H, Blau HM, Torti FM. Tumor necrosis factor inhibits human myogenesis in vitro. Mol Cell Biol. 1988; 8: 2295-2301.
15. Custer SK, Neumann M, Lu H, Wright AC, Taylor JP. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum Mol Genet. 2010; 19: 1741-1755.
16. Tews DS, Goebel HH. Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol. 1996; 55: 342-347.
17. Jonuleit H, Knop J, Enk AH. Cytokines and their effects on maturation, differentiation and migration of dendritic cells. Arch Dermatol Res. 1996; 289: 1-8.
18. Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol, Biol, Phys. 2004; 59: 21-26.
19. Doumit ME, Cook DR, Merkel RA. Fibroblast growth factor, epidermal growth factor, insulin-like growth factors, and platelet-derived growth factor-BB stimulate proliferation of clonally derived porcine myogenic satellite cells. J Cell Physiol. 1993; 157: 326-332.
20. Horikawa M, Higashiyama S, Nomura S, Kitamura Y, Ishikawa M, Taniguchi N. Upregulation of endogenous heparin-binding EGF-like growth factor and its role as a survival factor in skeletal myotubes. FEBS Lett. 1999; 459: 100-104.
21. Nalbandian A, Ghimbovschi S, Radom-Aizik S, Dec E, Vesa J, Martin B, Knoblach S, Smith C, Hoffman E, Kimonis VE. Global gene profiling of VCP-associated inclusion body myopathy. Clin Transl Sci. 2012; 5: 226-234.
22. Baeza-Raja B, Munoz-Canoves P. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol Biol Cell 2004; 15: 2013-2026.
23. Prokopchuk O, Liu Y, Wang L, Wirth K, Schmidtbleicher D, Steinacker JM. Skeletal muscle IL-4, IL-4Ralpha, IL-13 and IL-13Ralpha1 expression and response to strength training. Exerc Immunol Rev. 2007; 13: 67-75.
24. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, Gibbs JR, Brunetti M, Gronka S, Wuu J, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010; 68: 857-864.
25. Chan N, Le C, Shieh P, Mozaffar T, Khare M, Bronstein J, Kimonis V. Valosin-containing protein mutation and Parkinson's disease. Parkinsonism Relat Disord. 2012; 18: 107-109.
26. Yin HZ, Hsu CI, Yu S, Rao SD, Sorkin LS, Weiss JH. TNF-alpha triggers rapid membrane insertion of Ca(2+) permeable AMPA receptors into adult motor neurons and enhances their susceptibility to slow excitotoxic injury. Exp Neurol. 2012; 238: 93-102.
27. Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett. 1994; 165: 208-210.